| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/28/1990 | WO1990008776A1 Stabilized, potent grf analogs |
| 07/28/1990 | CA2045692A1 Processes for producing polypeptide inhibitors of platelet activation and methods, combinations and compositions using them |
| 07/28/1990 | CA2026776A1 Stabilized, potent grf analogs |
| 07/27/1990 | WO1990008773A1 Peptides with sulphate ester groups |
| 07/27/1990 | CA2046324A1 Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle |
| 07/27/1990 | CA2026005A1 Peptides with sulphate ester groups |
| 07/27/1990 | CA2025020A1 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
| 07/27/1990 | CA2008641A1 Process for the preparation of proteins inhibiting the lymphocytotoxicity and of the complement and proteins thus obtained |
| 07/26/1990 | WO1990008775A1 POLYPEPTIDES HAVING A HUMAN β ADRENERGIC RECEPTOR ACTIVITY, AND PLAYING A ROLE IN LIPOLYTIC RESPONSE, NUCLEIC ACIDS CODING FOR THESE POLYPEPTIDES AND USE OF SAID POLYPEPTIDES FOR SCREENING SUBSTANCES WHICH ACT ON THESE POLYPEPTIDES |
| 07/26/1990 | WO1990008324A1 Cancer related haptoglobin (hpr) |
| 07/26/1990 | WO1990008198A1 Compositions and methods for treating or preventing aids, arc and hiv infection |
| 07/26/1990 | WO1990008197A1 Process for testing for pathogenic listeria bacteria |
| 07/26/1990 | WO1990008195A1 Monoclonal antibody to human type ix collagen |
| 07/26/1990 | WO1990008188A1 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
| 07/26/1990 | WO1990008187A1 Soluble two domain cd2 protein |
| 07/26/1990 | WO1990008164A1 Somatotropin analogs |
| 07/26/1990 | WO1990008163A1 Pdgf-a, pdgf-aa, pdgf-ab, process for producing them and drugs containing them |
| 07/26/1990 | WO1990008161A1 Peptide-mediated modulation of t-cell recognition as a means of affecting immune responses |
| 07/26/1990 | WO1990008160A1 Growth factor receptor-like peptides without tyrosine-kinase activity |
| 07/26/1990 | WO1990008158A1 Method of recovering purified epi protein from a solution especially a fermentation solution |
| 07/26/1990 | WO1990007937A1 Pregnancy specific proteins applications |
| 07/26/1990 | WO1990007934A1 Polyvalent metal ion-containing antibody combining site catalysts |
| 07/26/1990 | WO1990007929A1 Site specific in-vivo activation of therapeutic drugs |
| 07/26/1990 | WO1990007863A1 A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide |
| 07/26/1990 | WO1990007862A2 Generation and selection of novel dna-binding proteins and polypeptides |
| 07/26/1990 | WO1990007861A1 CHIMERIC IMMUNOGLOBULINS SPECIFIC FOR p55 TAC PROTEIN OF THE IL-2 RECEPTOR |
| 07/26/1990 | WO1990006949A3 Peptide derivatives |
| 07/26/1990 | DE3906832A1 Verfahren zur bestimmung von pathogenen listeria-bakterien A method for the determination of pathogenic Listeria bacteria |
| 07/26/1990 | DE3900770A1 Verfahren zur herstellung von pdgf-a und pdgf-aa Process for the preparation of PDGF-A and PDGF-AA |
| 07/26/1990 | CA2045126A1 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
| 07/26/1990 | CA2008697A1 Inhibition of plant cell respiration |
| 07/26/1990 | CA2008696A1 Regulation of plant gene expression |
| 07/25/1990 | WO1990008774A1 Immunogenic compositions against gastrin peptides |
| 07/25/1990 | EP0379342A2 New FK-506 cytosolic binding protein |
| 07/25/1990 | EP0379338A2 Human insulin-like growth factor analogs and their production in yeast |
| 07/25/1990 | EP0379295A2 Anti-tryptase antibody and composition for treatment of AIDS using the same |
| 07/25/1990 | EP0379162A2 Process for the renaturation of false recombinants of insulin precursors |
| 07/25/1990 | EP0378929A2 Membrane proteins and peptides of haemophilus influenzae type b |
| 07/25/1990 | EP0378924A2 Detection of neurological disease or dysfunction |
| 07/25/1990 | EP0378881A1 Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines |
| 07/25/1990 | EP0378827A1 Use of interleukin-4 for lowering blood glucose levels and/or effecting weight reduction |
| 07/25/1990 | EP0378732A1 Serum proteins related to autoimmune disease |
| 07/25/1990 | EP0378676A1 Tumor necrosis enhancing factor and methods of preparation and use |
| 07/25/1990 | EP0378671A1 Insulinomimetic and insulin receptor binding site peptides. |
| 07/25/1990 | EP0378666A1 Interleukin ii analogs |
| 07/25/1990 | EP0378576A1 Transduced fibroblasts and uses therefor. |
| 07/25/1990 | EP0213175B1 Cysteine-depleted muteins of biologically active human tumor necrosis factor proteins |
| 07/25/1990 | EP0101506B1 Materials and methods for herpes simplex virus vaccination |
| 07/25/1990 | CN1044103A Anti-hcg antibodies |
| 07/25/1990 | CN1044101A Polypeptides isolated from venom of spider hololena curta |
| 07/25/1990 | CA2008622A1 Polypeptides antigens or vaccines protective against babesiosis |
| 07/24/1990 | US4943674 Fruit specific transcriptional factors |
| 07/24/1990 | US4943628 HIV peptide-inducted T cell stimulation |
| 07/24/1990 | US4943627 Prevention, treatment and detection of aids |
| 07/24/1990 | US4943562 Tetra- and pentapeptides containing the lysyl-arginyl-aspartyl sequence and their applications as medicines, particularly anti-thrombotic medicines |
| 07/24/1990 | US4943561 Antitumor |
| 07/24/1990 | US4943531 Expression of enzymatically active reverse transcriptase |
| 07/24/1990 | US4943529 Kluyveromyces as a host strain |
| 07/24/1990 | US4943527 Mature apoai protein production under serum free culturing conditions |
| 07/24/1990 | CA2025899A1 Site specific in-vivo activation of therapeutic drugs |
| 07/24/1990 | CA2008462A1 Tenascin-induced cell attachment and the tenascin receptor |
| 07/23/1990 | CA2008360A1 Myocardial infarction immunoassay |
| 07/21/1990 | CA2008246A1 Process for renaturing incorrect recombinants of insulin precursor |
| 07/21/1990 | CA2008245A1 Process for the preparation of an insulin precursor |
| 07/21/1990 | CA2008244A1 A signal peptide for the secretion of peptides in escherichia coli, a process for obtaining it and its use |
| 07/19/1990 | DE3900688A1 Haemoglobin modified with negative charges, and its use as blood substitute |
| 07/19/1990 | CA2046925A1 Pregnancy specific proteins applications |
| 07/19/1990 | CA2045583A1 Compositions and methods for treating or preventing aids, arc and hiv infection |
| 07/19/1990 | CA2005358A1 Somatotropin analogs |
| 07/19/1990 | CA2000355A1 Human fc-gamma receptor iii |
| 07/18/1990 | WO1990008194A1 PROCESS FOR PRODUCTION OF C-TERMINAL α-AMIDATED PEPTIDE |
| 07/18/1990 | WO1990008190A1 RECOMBINANT C-TERMINAL α-AMIDATING ENZYME OF HUMAN THYROID ORIGIN |
| 07/18/1990 | EP0378477A1 Complement inhibitory factor, its characterization and applications |
| 07/18/1990 | EP0378418A2 Immune cell proliferation inhibitors |
| 07/18/1990 | EP0378364A2 Analogues of PF4 and fragments thereof, and pharmaceutical compositions containing them |
| 07/18/1990 | EP0378224A2 Method of detecting small cell carcinoma and use of acylpeptide hydrolase encoding sequences therefor |
| 07/18/1990 | EP0378204A2 Method for severing an analyte from its binding protein |
| 07/18/1990 | EP0378203A2 Cobalamine-acid hydrazides and cobalamine conjugates derived therefrom |
| 07/18/1990 | EP0378171A2 The use of human BCDF for preparing a composition for treating thrombocytopenia |
| 07/18/1990 | EP0378107A2 Method of preparing natural products free of viruses |
| 07/18/1990 | EP0378078A1 Motilin-like polypeptide and use thereof |
| 07/18/1990 | EP0377855A2 Endothelial cell growth factor |
| 07/18/1990 | EP0377842A1 Prototype FeLV isolates for use in disease models and vaccines |
| 07/18/1990 | EP0377711A1 Serotyping dna probes |
| 07/18/1990 | EP0377657A1 Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3 |
| 07/18/1990 | EP0377582A1 Lipid microemulsions for culture media. |
| 07/18/1990 | EP0377579A1 Recombinant fibroblast growth factors |
| 07/18/1990 | CN1043939A Process for preparing 63-carboxyamides of teicoplanin antibiotics |
| 07/18/1990 | CN1043875A Novel 1 l-2 receptor-specific human immunoglobins |
| 07/18/1990 | CN1043874A Cpf peptide compositions and uses |
| 07/17/1990 | US4942131 Monoclonal antibody and method for preparation of hybridoma producing said antibody |
| 07/17/1990 | US4942125 Cloning vectors for hepatitis, polypeptides, antigens, analysis of antibodies |
| 07/17/1990 | US4942123 ppRB110 -phosphoprotein the retinoblastoma susceptibility gene product |
| 07/17/1990 | CA2007886A1 Human insulin-like growth factor analogs with reduced binding to 28 k igf binding proteins and their production in yeast |
| 07/17/1990 | CA2007818A1 Polyvalent metal ion-containing antibody combining site catalysts |
| 07/17/1990 | CA2006700A1 Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines |
| 07/17/1990 | CA1271900A1 Toxin conjugates |
| 07/17/1990 | CA1271899A1 Grf analogs |
| 07/17/1990 | CA1271898A1 Grf analogs |
| 07/17/1990 | CA1271717A1 Polypeptides useful in vaccination against enteroviruses |